Skip to content

Arcosa

US · ACA #1756 by market cap Listed 1970
149.15 0.00 0.00%
Periodic snapshot; not a real-time feed. · 2026-11-19 19:54

Price chart

149.15116.41149.152026-04-242026-10-22
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ACA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +32.3% on average (3-month/1-year).
  • Short interest has risen to 3.7% of float.
  • Analyst tilt is Hold.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall A-

The radar needs all six factors. Available grades are shown below.

Valuation B-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 15.0x Better than 59%
Forward P/E 32.7x Better than 15%
Price / Sales 2.5x Better than 49%
P/E vs own 5-yr range 25th pctl Better than 81%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 8.7% Better than 60%
Net income CAGR (3Y) -5.4% Better than 33%
Free cash flow CAGR (3Y) 69.1% Better than 89%
Profitability C+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 22.4% Better than 21%
Operating margin 11.9% Better than 56%
Net margin 7.2% Better than 51%
Return on equity 8.2% Better than 45%
Return on invested capital 7.2% Better than 56%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 2.9% Better than 80%
6-month return 23.6% Better than 86%
12-month return (ex latest month) 45.7% Better than 81%
Distance below 52-week high 0.0% Better than 100%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.2x Better than 61%
Debt to assets 30.5% Better than 40%
Interest coverage 3.2x Better than 47%
Free cash flow / net income 84.2% Better than 28%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +1.46%
1M +1.74%
3M +2.77%
6M +26.62%
YTD +40.46%
1Y +61.77%
3Y +118.66%
5Y +185.46%

Key statistics

Price & volume

Prev close
149.15
Open
0.00
Day range
0.00 - 0.00
Avg price
0.00
Volume
0
Turnover
0
Amplitude
0.00%
52-week range
99.75 - 149.21

Valuation

P/E
35.18
P/E (TTM)
14.96
P/B
2.46
EPS
4.24
Net profit
208.21M
Net assets
2.98B

Share structure

Market cap
7.32B
Float cap
7.18B
Shares out
49.11M
Float shares
48.15M

Dividend & listing

Dividend (TTM)
0.20
Listing date
1970-01-01
52-week range 100% of range
99.75 149.21

Trading activity

Net capital flow main funds, last 45 sessions

-26.59M net over the window

Short interest

Shares short
1.81M
As of
2026-10-15

Frequently asked questions

What is the current stock price of Arcosa (ACA)?

Arcosa last traded at 149.15. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Arcosa's market cap?

About 7.32B.

What is the P/E ratio of Arcosa?

The trailing twelve-month P/E is 14.96, below its own 5-year average of 29.94 — toward the bottom of its historical range (24.70% percentile). See the Valuation tab for the full history.

Does Arcosa pay a dividend?

Yes. The trailing dividend yield is 0.13%. Per-share dividends have risen or held for 7 straight years through 2025. See the Dividends tab for the full payment history.

Is Arcosa a buy according to analysts?

The consensus of 1 analysts is a Hold rating, with an average 12-month price target of 150.00, which implies 0.6% upside from the current price. This is not investment advice.

What is Arcosa's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Arcosa a B (Buy). Twelve-month momentum in the top 13% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-11-19 19:54:59 · For reference only, not investment advice and not tailored to your situation.

Arcosa discussion 0 comments

Add a comment